130 results
424B5
VBIVQ
VBI Vaccines Inc
15 May 24
Prospectus supplement for primary offering
4:16pm
to the standards and requirements of regulatory agencies;
the impact of the ongoing COVID-19 pandemic on our clinical studies, research programs, manufacturing
424B5
VBIVQ
VBI Vaccines Inc
11 Apr 24
Prospectus supplement for primary offering
9:06am
scale to the standards and requirements of regulatory agencies;
the impact of the ongoing COVID-19 pandemic on our clinical studies, research
8-K
EX-99.1
VBIVQ
VBI Vaccines Inc
2 Apr 24
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
8:00am
and will also include a pan-coronavirus MLE candidate to contribute toward future epidemic and pandemic preparedness.
About the mRNA-Launched eVLP (MLE) Program
8-K
EX-99.1
d6gdmj4tu 4qgfu
14 Feb 24
VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences
8:34am
8-K
EX-99.1
t308d
7 Sep 23
VBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901 in Recurrent GBM
8:00am
8-K
EX-99.1
ath 0io43b00
6 Sep 23
Regulation FD Disclosure
9:12am
8-K
EX-99.1
c9weoby61379s
14 Aug 23
VBI Vaccines Reports Second Quarter 2023 Financial Results
8:00am
8-K
EX-99.1
6aa3wrpa6ew
24 Jul 23
VBI Vaccines Announces Closing of Underwriters’ Partial Exercise of Option to Purchase Additional Common Shares
8:00am
8-K
EX-99.1
nk661l
19 Jul 23
VBI Vaccines Announces PreHevbri® is Now Available in the Netherlands and Belgium for the Prevention of Hepatitis B in Adults
8:00am
424B5
oq5ra4gdiy6hsixwp2
7 Jul 23
Prospectus supplement for primary offering
5:25pm
424B5
mtrckg81
7 Jul 23
Prospectus supplement for primary offering
5:20pm
8-K
EX-99.1
a77pcucqji
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
8-K
EX-99.2
2a99dnwq2jef kmb7v
6 Jul 23
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares and Warrants
6:47pm
424B5
72kb4jr
5 Jul 23
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
8ncuu4
5 Jul 23
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-99.1
xzwrps2l1y8ai44csenr
15 Jun 23
VBI Vaccines Announces PreHevbri® is Now Available in the United Kingdom for the Prevention of Hepatitis B in Adults
8:00am